Schedule 13D ownership disclosure

Elicio Therapeutics, Inc.

Security class unavailable · CUSIP: 28657F103

Event date: 2023-06-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.1100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-165265
Form type
SC 13D
Filer
Clal Biotechnology Industries Ltd.
CIK
CIK 1468950
Filed
Jun 12, 2023
Reporting period
Jun 01, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub